SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-024270
Filing Date
2014-06-17
Accepted
2014-06-17 17:19:22
Documents
1
Period of Report
2014-06-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rrd411896.html 4  
1 PRIMARY DOCUMENT rrd411896.xml 4 3671
  Complete submission text file 0001181431-14-024270.txt   5330
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Issuer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 246 HOLLY DRIVE CHALFONT PA 18914
Business Address
Singhvi Rahul (Reporting) CIK: 0001322731 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35560 | Film No.: 14926075